ArticleScientific reports2025

The efficacy and safety analysis of D-TACE combined with donafenib and tislelizumab in recurrent hepatocellular carcinoma after surgery.

Haohao Lu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.